Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.

Cite this paper

@article{Simpson2013LopinavirritonavirVD, title={Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.}, author={Kit N. Simpson and Pamela Pen-Erh Pei and J{\"{o}rgen M{\"{o}ller and Robert W. Baran and Birgitta Dietz and William Woodward and Kristen Migliaccio-Walle and J. Jaime Caro}, journal={PharmacoEconomics}, year={2013}, volume={31 5}, pages={427-44} }